Truist analyst Bill Chappell lowered the firm’s price target on Olaplex Holdings to $3 from $7 but keeps a Buy rating on the shares. The firm is updating its model after the company’s Q4 results and below-consensus guidance, though it also believes that Olaplex is already generating strong revenue growth and EBITDA margins and appears to be at the infant stages of its growth opportunity, the analyst tells investors in a research note.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on OLPX:
- OLAPLEX Reports Fourth Quarter and Fiscal Year 2023 Results
- Olaplex Holdings sees Q1 revenue $92M-$97M, consensus $113.15M
- Olaplex Holdings sees 2024 revenue $435M-$463M, consensus $476.97M
- Olaplex Holdings reports Q4 adjusted EPS 3c, consensus 3c
- Olaplex Holdings, Inc. Announces Participation in the Raymond James 45th Annual Institutional Investors Conference on March 5th
